Ken Griffin Pa Vmed Inc. Call Options Transaction History

Citadel Advisors LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 14, 2023	SELL	$0.22 - $0.5 $198 - $450	-900 Reduced 1.98%	44,500 $13,000
Q2 2023 Aug 14, 2023	SELL	$0.35 - $0.56 $5,040 - $8,064	-14,400 Reduced 24.08%	45,400 $18,000
Q1 2023 May 15, 2023	SELL	$0.36 - $0.63 $27,972 - $48,951	-77,700 Reduced 56.51%	59,800 $22,000
Q4 2022 Feb 14, 2023	SELL	$0.41 - $18.6 $3,239 - $146,940	-7,900 Reduced 5.43%	137,500 $66,000
Q3 2022 Nov 14, 2022	BUY	$0.57 - $34.65 $18,981 - $1.15 Million	33,300 Added 29.71%	145,400 $125,000

2.24M

Ticker PAVM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 90,999,104
Market Cap $106M
Description
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.